Literature DB >> 28636312

Combining Protein and miRNA Quantification for Bladder Cancer Analysis.

Ruixue Duan1, Zhenyu Zhang1, Fuxin Zheng1, Longwang Wang2, Ju Guo3, Tianchi Zhang1, Xiaomeng Dai2, Shengwei Zhang1, Dong Yang4, Renrui Kuang2, Gongxian Wang3, Chaohong He4, Abdul Hakeem1, Chang Shu1, Ping Yin1, Xiaoding Lou1, Fuqing Zeng1, Huageng Liang1, Fan Xia1.   

Abstract

We combine the telomerase extension reaction and microRNA (miRNA)-induced rolling circle amplification, followed by graphene oxide (GO) and nicking enzyme-assisted signal amplification as a method to analyze telomerase and miRNA-21 in urine samples with the following merits. First, it is a binary assay and can simultaneously output double signals that correspond to the quantities of telomerase and miRNA, respectively. Second, telomerase activity is enhanced by using a DNA molecular beacon probe to inhibit the formation of G-quadruplex. Third, background noise is decreased significantly via introduction of GO. Fourth, performance tests on about 258 urine samples demonstrate that this binary assay can distinguish between urine from bladder cancer patients, those with cystitis, and normal individuals. Finally, this strategy also shows great potential in distinguishing between muscle-invasive bladder cancers and non-muscle-invasive bladder cancers. The proposed strategy will greatly contribute to clinical decision-making and individualized treatments.

Entities:  

Keywords:  binary assay; bladder cancer; microRNA; muscle-invasive bladder cancers; non-muscle-invasive bladder cancers; signal amplification; telomerase

Mesh:

Substances:

Year:  2017        PMID: 28636312     DOI: 10.1021/acsami.7b05639

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  5 in total

1.  Enhanced plasma miR-26a-5p promotes the progression of bladder cancer via targeting PTEN.

Authors:  Hui Wang; Zhao Hu; Li Chen
Journal:  Oncol Lett       Date:  2018-07-17       Impact factor: 2.967

2.  MiR-411 suppresses the development of bladder cancer by regulating ZnT1.

Authors:  Yang Liu; Tao Liu; Hongwei Jin; Lei Yin; Hongyuan Yu; Jianbin Bi
Journal:  Onco Targets Ther       Date:  2018-12-04       Impact factor: 4.147

Review 3.  Nanotechnology in Bladder Cancer: Diagnosis and Treatment.

Authors:  Mahmood Barani; Seyedeh Maryam Hosseinikhah; Abbas Rahdar; Leila Farhoudi; Rabia Arshad; Magali Cucchiarini; Sadanand Pandey
Journal:  Cancers (Basel)       Date:  2021-05-05       Impact factor: 6.639

4.  Detection of urinary microRNA biomarkers using diazo sulfonamide-modified screen printed carbon electrodes.

Authors:  Daniel A Smith; Kate Simpson; Matteo Lo Cicero; Lucy J Newbury; Philip Nicholas; Donald J Fraser; Nigel Caiger; James E Redman; Timothy Bowen
Journal:  RSC Adv       Date:  2021-05-25       Impact factor: 4.036

Review 5.  Optical Biosensors for the Detection of Rheumatoid Arthritis (RA) Biomarkers: A Comprehensive Review.

Authors:  José Javier Imas; Carlos Ruiz Zamarreño; Pablo Zubiate; Lorena Sanchez-Martín; Javier Campión; Ignacio Raúl Matías
Journal:  Sensors (Basel)       Date:  2020-11-04       Impact factor: 3.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.